参考文献:1. Chaimowitz NS, et al. STAT1 Gain of Function, Type1 Diabetes, and Reversal with JAK Inhibition. New England Journal of Medicine.2020;383(15):1494-6. doi: 10.1056/NEJMc2022226.2. Bharadwaj U, et al. Targeting Janus Kinases and Signal Transducer and Activator ofTranscription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale,Progress, and Caution. Pharmacological Reviews. 2020;72(2):486. doi:10.1124/pr.119.018440.3. Cao Y, et al. Ruxolitinib in treatment ofsevere coronavirus disease 2019 (COVID-19): A multicenter, single-blind,randomized controlled trial. Journal of Allergy and Clinical Immunology.2020;146(1):137-46.e3. doi: 10.1016/j.jaci.2020.05.019. 4. Mackay-Wiggan J, et al. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severealopecia areata. JCI insight. 2016;1(15).5. Rosmarin D, et al. Ruxolitinib cream for treatment of vitiligo: a randomised,controlled, phase 2 trial. The Lancet. 2020;396(10244):110-20. doi:10.1016/S0140-6736(20)30609-7. (作者:张洪涛,笔名“一节生姜”。宾夕法尼亚大学医学院病理及实验医药系研究副教授,研究领域:癌症的靶向治疗以及免疫治疗。著有科普读物:《吃什么呢?——舌尖上的思考》,《如果舌尖能思考》。可以谈最前沿的医学研究,也可以讲最通俗的故事。)